Roddy Boyd, the journalist behind the Valeant Pharmaceuticals Intl VRX specialty pharmacy controversy months ago, has released a new report on Insys Therapeutics Inc INSY.
Boyd's piece titled "The Brotherhood of Thieves" highlights how Insys was able to double the insurance approval rates of Subsys, over competitors that were much more established.
Continuing his initial report on the company in December, Boyd followed up saying, "executives continued to pressure employees to develop new ways to mislead insurance companies into granting coverage to patients prescribed its drug Subsys."
Related Link: Depomed Validates Horizon Pharma Rejection Offer
In his report, Boyd obtained audio recording of a meeting held in November that shows (according to Boyd) executive Jeff Kobos admitting to the unit's dishonesty. Boyd also highlights, "conversational gambits" to deflect pharmacy benefit manager worker questions with.
Benzinga reached out to Insys to comment on the report.
Shares of Insys Therapeutics remain volatile off the open, trading down 3.47 percent at $21.78.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
